Medical professionals really should take into consideration whether or not their clients with fundamental NAION risk variables could possibly be adversely afflicted by usage of PDE5 inhibitors. Individuals who have previously skilled NAION are at amplified threat of NAION recurrence. Consequently, PDE5 inhibitors, like LEVITRA, ought to be applied